Theragene Pharmaceuticals, Inc.
Records under this name other than the patents Theragene Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Theragene Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,636,998 | Method for enhanced uptake of viral vectors in the myocardium Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,221,738 | Method for enhanced uptake of viral vectors in the myocardium Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,583,662 | Methods and compositions for consistent intracoronary administration of a biologic Formerly held In force · USPTO record | In force | USPTO record |